JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on December 10, 2008; DOI: 10.1124/jpet.108.142034


0022-3565/09/3283-991-999$20.00
JPET 328:991-999, 2009
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.108.142034v1
328/3/991    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fernandes, D.
Right arrow Articles by Assreuy, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fernandes, D.
Right arrow Articles by Assreuy, J.

CARDIOVASCULAR

Late, but Not Early, Inhibition of Soluble Guanylate Cyclase Decreases Mortality in a Rat Sepsis Model

Daniel Fernandes, Regina Sordi, Letícia Kramer Pacheco, Geisson Marcos Nardi, Bettina Tomio Heckert, Christina Gaspar Villela, Amanda Revoredo Lobo, Christina Barja-Fidalgo, and Jamil Assreuy

Department of Pharmaceutical Sciences, Universidade Estadual de Ponta Grossa, Paraná, Brazil (D.F.); Department of Pharmacology, Universidade Federal de Santa Catarina, Santa Catarina, Brazil (R.S., L.K.P., B.T.H., J.A.);Área de Ciências Biológicas e da Saúde, Universidade do Oeste de Santa Catarina, Joaçaba, Santa Catarina, Brazil (G.M.N.); and Department of Pharmacology, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil (C.G.V., A.R.L., C.B.-F.)

Overproduction of nitric oxide and activation of soluble guanylate cyclase (sGC) are important in sepsis-induced hypotension and hyporesponsiveness to vasoconstrictors. A time course of the expression and activity of sGC in a sepsis model [cecal ligation and puncture (CLP)] was evaluated in rats. Soluble GC {alpha}-1 and β-1 subunit mRNA levels increased in the lungs, but not in the aorta. However, in both tissues, the protein levels increased 24 h after sepsis and remained high for up to 48 h. Sodium nitroprusside-stimulated cGMP accumulation was higher 48 h after CLP in the lung and aorta. NOS-2 protein expression peaked 24 h after CLP, decreasing thereafter. The impact of inhibiting the expression of sGC early (8 h) or late (20 h) on vascular reactivity and the indexes of organ damage and mortality were also studied. Late administration of methylene blue (MB) or ODQ (1H-[1,2,4]-oxadiazole[4,3-a]quinoxalin-1-one) restored the blood pressure and vascular responsiveness to vasoconstrictors to normal levels but was ineffective in early sepsis. Late MB injection reduced the plasma levels of urea, creatinine, and lactate. MB improved the survival if administered late, but it increased the mortality when administrated early after sepsis onset. The increased sGC expression/activity may be relevant for the late hypotension and hyporesponsiveness to vasoconstrictors in sepsis. In accordance, MB increased survival if administered in late sepsis, but not in early sepsis. Therefore, differential responsiveness to sGC during the course of sepsis may determine the success or failure of treatment with sGC inhibitors.


Received for publication June 7, 2008
Accepted December 9, 2008.

Address correspondence to: Dr. Jamil Assreuy, Department of Pharmacology, University Campus, Trindade, Biological Sciences Centre, Block "D," Florianopolis, Santa Catarina 88049-900, Brazil. E-mail: assreuy{at}farmaco.ufsc.br




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. S. Buys, A. Cauwels, M. J. Raher, J. J. Passeri, I. Hobai, S. M. Cawley, K. M. Rauwerdink, H. Thibault, P. Y. Sips, R. Thoonen, et al.
sGC{alpha}1{beta}1 attenuates cardiac dysfunction and mortality in murine inflammatory shock models
Am J Physiol Heart Circ Physiol, August 1, 2009; 297(2): H654 - H663.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2009 by the American Society for Pharmacology and Experimental Therapeutics.